Becton Dickinson and Co.BDX
Health Care · Health Care Equipment & Services · NYSE · United States · bd.com
Becton, Dickinson and Company (BD) is a global medical technology company headquartered in Franklin Lakes, New Jersey, that manufactures and sells medical devices, instrument systems, and reagents for healthcare institutions, life science researchers, clinical laboratories, and pharmaceutical companies. The company's products include syringes, infusion systems, diagnostics platforms, and surgical instruments sold in over 190 countries.
Key ratios
Operating cash flow growth
3.0%TTM
2025
-9.7%2024
27.1%2023
13.5%
EPS growth
45.8%TTM
2025
-0.7%2024
14.9%2023
-5.2%
FCF / Sales
11.5%TTM
2025
12.2%2024
15.2%2023
10.9%
Net margin
4.2%TTM
2025
7.7%2024
8.5%2023
7.7%
ROA
4.3%TTM
2025
4.1%2024
3.2%2023
2.5%
ROE
6.6%TTM
2025
6.5%2024
6.6%2023
6.0%
Revenue growth
18.5%TTM
2025
8.2%2024
4.2%2023
2.7%
Recent news
BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products
Track BDX in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer